Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis

[1]  A. Ochiai,et al.  Total microvessel perimeter per tumor area is a predictor of radiosensitivity in early-stage glottic carcinoma. , 2009, International journal of radiation oncology, biology, physics.

[2]  Y. Horibe,et al.  Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy. , 2008, Auris, nasus, larynx.

[3]  B. Emami,et al.  Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. , 2007, International Journal of Radiation Oncology, Biology, Physics.

[4]  Y. Niibe,et al.  Effectiveness of concurrent radiation therapy with UFT or TS-1 for T2N0 glottic cancer in Japan. , 2007, Anticancer research.

[5]  K. Nagata,et al.  A Phase I Study of Concurrent Chemoradiotherapy with S-1 for T2N0 Glottic Carcinoma , 2007, Oncology.

[6]  Christopher U. Jones,et al.  26: A Randomized Trial of Hyperfractionation Versus Standard Fractionation In T2 Squamous Cell Carcinoma of The Vocal Cord , 2006 .

[7]  K. Ang,et al.  American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Y. Kitamoto,et al.  Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. , 2006, International journal of radiation oncology, biology, physics.

[9]  H. Yamazaki,et al.  Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. , 2006, International journal of radiation oncology, biology, physics.

[10]  Y. Itoh,et al.  Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer , 2006, Radiation Medicine.

[11]  L. Livi,et al.  Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. , 2005, International journal of radiation oncology, biology, physics.

[12]  L. Livi,et al.  Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. , 2005, International journal of radiation oncology, biology, physics.

[13]  R. Talamini,et al.  Radiotherapy for patients with early‐stage glottic carcinoma , 2003, Cancer.

[14]  A. Garden,et al.  Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? , 2003, International journal of radiation oncology, biology, physics.

[15]  Z. Liao,et al.  Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences. , 2002, International journal of radiation oncology, biology, physics.

[16]  S. Ell,et al.  Overexpression of Bcl‐2 in squamous cell carcinoma of the larynx: A marker of radioresistance , 2002, International journal of cancer.

[17]  M. Masuda,et al.  “FAR” chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma , 2002, Head & neck.

[18]  K. Takeda,et al.  DNA ploidy analysis performed prospectively using fresh tumor samples in early glottic carcinoma treated with radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[19]  K. Johansson,et al.  Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer. , 2002, International journal of radiation oncology, biology, physics.

[20]  W. Mendenhall,et al.  T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Agarwal,et al.  Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. , 2000, International journal of radiation oncology, biology, physics.

[22]  S. Fisher,et al.  P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. , 2000, International journal of radiation oncology, biology, physics.

[23]  W. Regine,et al.  Second malignant neoplasia in patients with T1 glottic cancer treated with radiation , 1998, The Laryngoscope.

[24]  N. Mohideen,et al.  Effect of tumor bulk on local control and survival of patients with T1 glottic cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  A. Hasman,et al.  Heterogeneity of stage II glottic carcinoma and its therapeutic implications. , 1987, International journal of radiation oncology, biology, physics.